Find Clinical Trial

Effects of acute and chronic oral administration of S 44121 versus placebo on cardiac arrhythmia during exercise testing in patients with catecholaminergic polymorphic ventricular tachycardia type 1 – A randomized, parallel-group, international multicentre study including a 8-week double-blind placebo controlled period followed by a 8-week single-blind period – Phase II exploratory study


← Back
Study Phase

Phase 2

Therapeutic Area

Cardiovascular Diseases

IndicationCatecholaminergic Polymorphic Ventricular Tachycardia
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

S044121

Active Substance CodeS044121
Protocol CodeCL2-44121-008
EudraCT Code2011-000579-15


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility